We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Image of Sarah Whelan, PhD

Sarah Whelan, PhD

Science Writer

Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.

Got a question for Sarah Whelan, PhD?

Get in touch using the contact form linked here and we’ll get back to you shortly

Published Content
Total: 256
Dr. Khadijah A. Mitchell

Cancer Research, Mentorship and Confidence in Your Competence With Dr. Khadijah A. Mitchell

Cancer researcher Dr. Khadijah A. Mitchell reflects on her journey into studying health disparities, touches on the importance of mentorship and shares some inspiring advice for women and girls considering a career in STEMM.
A lab worker pipetting media into a cell culture dish.
Industry Insight

Recreating Organ-Specific Tumor Environments In Vitro

At ELRIG’s Research & Innovation 2024 event, Technology Networks spoke to Dr. Véronique De Conto, project leader in in vitro pharmacology at HCS Pharma, to learn more about their powerful tools for in vitro metastasis propagation.
A scientist pipetting into an assay plate.

AI Method Accelerates Drug Discovery for Parkinson’s 10-Fold, Study Finds

University of Cambridge researchers have harnessed the power of artificial intelligence (AI) to speed up the screening of new drugs to treat Parkinson’s disease.
A person holding their hand up to a window while it rains outside.

Ketamine Reduces Depression After Childbirth, Study Finds

A single low dose of esketamine – the active form of the anesthetic drug, ketamine – can reduce depressive episodes when given immediately after childbirth, a new study has found.
A person wearing a virtual reality headset.

Virtual Reality Therapy Helps Decrease Cancer Pain, Study Finds

A new study has used virtual reality (VR) to help reduce cancer pain for hospitalized patients, potentially providing a non-invasive and non-pharmacologic approach to improve the quality of life for people with cancer.
Image of a blue and red drug capsule showing a chemical structure.

ALS Drug Pulled From Market After Disappointing Trial Results

The amyotrophic lateral sclerosis (ALS) drug Relyvrio has been pulled from US and Canadian markets by its maker, Amylyx Pharmaceuticals, after topline trial data showed it worked no better than a placebo.
A digital image of a brain with multicolored threads emerging from it.

Diabetes Drug Shows Promise for Parkinson’s Disease in Trial

Results from a Phase 2 clinical trial suggest that lixisenatide – a drug used to treat type 2 diabetes – may also slow the progression of Parkinson’s disease symptoms.
Computer-generated image of cells.

Ancient DNA May Uncover Ethnic Differences in Childhood Cancer

Researchers have harnessed ancient DNA to trace a genetic variant – one that increases the risk of a type of childhood cancer – back to the first people who migrated into the Americas approximately 13,000 years ago.
The Genetic Basis of Cancer infographic snippet

The Genetic Basis of Cancer

Cancer is inherently a genetic disease, and advances in our knowledge of the genetic basis of cancer can help to guide earlier diagnosis and improve treatments to benefit patients.
Bioprocessing infographic teaser

The Basics of Bioprocessing

Download this infographic to learn more about what bioprocessing is, the techniques and systems used in bioprocessing, and key considerations, challenges and future trends for the field.